CD4+CD56+ lineage negative hematopoietic neoplasm: So called blastic NK cell lymphoma

Journal of Korean Medical Science

Volumn 20, Issue 2, 2005, Pages 319-324

  Kim, Yoonjung ^a   Mi, Seon Kang ^b   Chan, Whan Kim ^b   Sung, Rohyun ^c   Ko, Young H ^d,e  

^a Soonchunhyang University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Samsung Medical Center   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

DNTTIP1 protein, human; Killer Cells, Natural; Lymphoma; Lymphoma, Blastic NK Cell; Receptor CD3 Complex, Antigen, T Cell

Indexed keywords

ANTINEOPLASTIC AGENT; CD133 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BLAST TRANSFORMATION; BONE MARROW TRANSPLANTATION; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CAUSE OF DEATH; CELL LINEAGE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GENE REARRANGEMENT; HEMATOPOIETIC SYSTEM TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; NATURAL KILLER CELL; PROTEIN EXPRESSION; SEPSIS; SKIN DEFECT; T LYMPHOCYTE; TUMOR GROWTH; TUMOR NECROSIS;

EID: 18244362553     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.2.319     Document Type: Article

References (28)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours, Pathology & Genetics Tumours of the Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer (IARC) Press, 2001; 214-5.
2. Petrella T, Comeau MR, Maynadie M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852-62.
3. Ko YH, Kim SH, Ree HJ. Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation. Histopathology 1998; 33: 547-53.
4. Ko YH, Kim SH, Park K, Ree HJ. CD4+CD56+CD68+ hematopoietic tumor of probable plasmacytoid monocyte derivation with weak expression of cytoplasmic CD3. J Korean Med Sci 2002; 17: 833-9.
5. Signoretti S, Murphy M, Cangi MG, Puddu P, Kadin ME, Loda M. Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis. Am J Pathol 1999; 154: 67-75.
6. Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. Br J Haematol 2001; 115: 225-8.
7. Almasri NM, Mitchell D, Braylan RC. Blastic natural killer cell. Am J Surg Pathol 1999; 23: 991-2.
8. Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Bene MC, Bensa JC, Briere F, Plumas J. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88: 941-55.
9. Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Suefuji H, Suzumiya J, Harada M, Kikuchi M. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification. Am J Surg Pathol 2003; 27: 1366-74.
10. Kazakov DV, Mentzel T, Burg G, Dummer R, Kempf W. Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol 2003; 149: 869-76.
11. Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen. Am J Hematol 2003; 74: 46-51.
12. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56 (+) TdT (+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002; 94: 2401-8.
13. Chang SE, Choi HJ, Huh J, Choi JH, Sung KJ, Moon KC, Koh JK. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman. Am J Dermatopathol 2002; 24: 72-5.
14. Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drenou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calvez G, Sainty D, Sotto MF, Trimoreau F, Bene MC. Clinical and biologic features of CD4 (+) CD56 (+) malignancies. Blood 2002; 99: 1556-63.
15. Aoyama Y, Yamane T, Hino M, Ohta K, Nakamae H, Yamamura R, Koh KR, Takubo T, Inoue T, Tatsumi Y, Tatsumi N. Blastic NK-cell lymphoma/leukemia with T-cell receptor gamma rearrangement. Ann Hematol 2001; 80: 752-4.
16. Bayerl MG, Rakozy CK, Mohamed AN, Vo TD, Long M, Eilender D, Palutke M. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. Am J Clin Pathol 2002; 17: 41-50.
17. Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, Palutke M. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Am J Clin Pathol 2001; 116: 168-76.
18. Yamada O, Ichikawa M, Okamoto T, Park C, Motoji T, Mizoguchi H, Shibuya A. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies. Br J Haematol 2001; 113: 153-60.
19. Liu Q, Ohshima K, Sumie A, Suzushima H, Iwasaki H, Kikuchi M. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms. Virchows Arch 2001; 438: 271-9.
20. Kluin PM, Feller A, Gaulard P, Jaffe ES, Meijer CJ, Müller-Hermelink HK, Pileri S. Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001; 38: 250-70.
21. Kojima H, Mukai HY, Shinagawa A, Yoshida C, Kamoshita M, Komeno T, Hasegawa Y, Yamashita Y, Mori N, Nagasawa T. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas. Int J Hematol 2000; 72: 477-83.
22. Isobe K, Tamaru JI, Nakamura S, Itami J, Aruga T, Uno T, Yasuda S, Mikata A, Ito H. Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression. Pathol Int 2001; 51: 55-9.
23. Koita H, Suzumiya J, Ohshima K, Takeshita M, Kimura N, Kikuchi M, Koono M. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am J Surg Pathol 1997; 21: 242-8.
24. Adachi M, Maeda K, Takekawa M, Hinoda Y, Imai K, Sugiyama S, Yachi A. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994; 47: 278-82.
25. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003; 101: 5007-9.
26. Alonso-C LM, Munoz JJ, Zapata AG. Delineation of intrathymic T, NK, and dendritic cell (DC) progenitors in fetal and adult rats: demonstration of a bipotent T/DC intermediate precursor. J Immunol 2001; 16: 3635-41.
27. Michie AM, Carlyle JR, Schmitt TM, Ljutic B, Cho SK, Fong Q, Zuniga-Pflucker JC. Clonal characterization of a bipotent T cell and NK cell progenitor in the mouse fetal thymus. J Immunol 2000; 164: 1730-3.
28. DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, Borowitz MJ. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol 1997; 21: 1223-30.